Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Fortis Malar Hospitals has informed BSE that its trading window for dealing in shares is closed from October 1, 2025, until 48 hours after the declaration of unaudited financial results for the quarter and half-year ending September 30, 2025. This is a routine compliance disclosure under SEBI's insider trading regulations, signed by Company Secretary Vinti Verma. No actual share purchase or sale by insiders is reported in this filing. The window closure simply means that designated insiders (directors, officers, employees) cannot trade in the stock until results are published and 48 hours have passed.
This is a standard regulatory notice and does not directly affect shareholder value. It signals that Q2 FY26 and H1 FY26 results are expected to be announced shortly after September 30, 2025, which investors should watch for as the next catalyst.